You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

AMINOSYN II 15% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aminosyn Ii 15% In Plastic Container patents expire, and when can generic versions of Aminosyn Ii 15% In Plastic Container launch?

Aminosyn Ii 15% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in AMINOSYN II 15% IN PLASTIC CONTAINER is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aminosyn Ii 15% In Plastic Container

A generic version of AMINOSYN II 15% IN PLASTIC CONTAINER was approved as amino acids by B BRAUN on April 13th, 2012.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMINOSYN II 15% IN PLASTIC CONTAINER?
  • What are the global sales for AMINOSYN II 15% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOSYN II 15% IN PLASTIC CONTAINER?
Summary for AMINOSYN II 15% IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOSYN II 15% IN PLASTIC CONTAINER
Pharmacology for AMINOSYN II 15% IN PLASTIC CONTAINER
Drug ClassAmino Acid

US Patents and Regulatory Information for AMINOSYN II 15% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc AMINOSYN II 15% IN PLASTIC CONTAINER amino acids INJECTABLE;INJECTION 020041-001 Dec 19, 1991 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.